CNEN

Search

Fujian Xianzhilou Biological Science and Technology Co., Ltd.Copyright © 1999-2018 300.cn All rights Reserved  闽ICP备05002116号 

Service

About     |     News     |    Product     |     Service     |     Contact     

NEWS

 

Cloud Conference on Ganoderma Lucidum

Page view
[Abstract]:
At 9:00 in the morning on May 7, more than a dozen Ganoderma industry experts and entrepreneur representatives from Fujian gathered at the headquarters of GanoHerb to exchange ideas with other Ganoderma industry leaders across China on the development of the Ganoderma industry by the cloud conference. This special "cloud conference" is the site of the 2020 working meeting of Ganoderma Professional Committee of China Association of Traditional Chinese Medicine.

At 9:00 in the morning on May 7, more than a dozen Ganoderma industry experts and entrepreneur representatives from Fujian gathered at the headquarters of GanoHerb to exchange ideas with other Ganoderma industry leaders across China on the development of the Ganoderma industry by the cloud conference. This special "cloud conference" is the site of the 2020 working meeting of Ganoderma Professional Committee of China Association of Traditional Chinese Medicine.

The meeting was chaired by Secretary-General Zhuang Hong. Chairman Yang Baoxue made a report on the "Working Report of the Ganoderma Special Committee 2019 and the Draft Work Plan 2020", sharing the key work done by the special committee in the past year and mentioning particularly that it is necessary to strengthen the combination of production and study, build a communication platform for the Ganoderma lucidum committee, expand business channels, consolidate platform power, strengthen the Ganoderma industry and enhance the international influence of Chinese Ganoderma academic research.

"During the epidemic, the deputy chairman unit represented by GanoHerb donated a total of about 700,000 yuan in cash and anti-epidemic materials worth 16.09 million yuan." At the meeting, Secretary-General Zhuang shared the summaries on public welfare activities made by committee units during the outbreak and proposed that all Ganoderma enterprises should cater to the market, pay close attention to the new opportunities for the development of traditional Chinese medicine, adjust the industrial model and structure, increase investment in scientific research, talent cultivation and cultural innovation, and promote the ecological development of the entire Ganoderma industry.

GanoHerb Supported Fujian Medical Team Leaving for Wuhan to Aid Coronavirus Control

Afterwards, a number of representatives of entrepreneurs who participated in the meeting shared their work priorities and experiences during the epidemic. "We responded actively to the government's call as soon as the epidemic occurred, and we made donations both in Fuzhou and Nanping. We donated about 5 million yuan of Lingzhi products to Fujian medical team leaving for Wuhan to aid coronavirus control. "After sharing the work done in the prevention and control of the epidemic, President Li Ye also specifically raised the current topic of medicinal and edible use of Ganoderma lucidum, and called on Ganoderma lucidum entrepreneurs to actively get familiarized with local policies and strive for the pilot project on bringing Ganoderma lucidum into medicinal and edible use in various provinces so that Ganoderma lucidum can better serve human health.

At the meeting, President Li Ye shared his priorities during the epidemic.

"This epidemic once again witnessed the importance of Ganoderma lucidum as a traditional Chinese medicine in supporting the healthy energy and strengthening immunity." In response to the advantages of traditional Chinese medicine in this epidemic, Professor Lin Zhibin proposed the following expectations for the future development of the Ganoderma industry: The first is to standardize the promotion of ganoderma health products without exaggeration; the second is to take advantage of the soon-to-be-released policy of regarding Ganoderma lucidum as the homology of medicine and food to develop ganoderma food and to separate Ganoderma decoction pieces from Ganoderma health food; the third is to speed up the research and rational application of Ganoderma lucidum pharmacology so as to ensure a benign development of the Ganoderma industry.